1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. APELLIS PHARMACEUTICALS INC
Apellis Pharmaceuticals Inc XNAS: APLS

Apellis Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

Read More
20.07 0.56 (2.87%)
43.81% Fall from 52W High
1.1M
XNAS Volume

XNAS 12 Nov, 2025 3:36 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Apellis Pharmaceuticals Inc is scheduled for today, for the purpose of Stifel 2025 Healthcare Conference See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
37.3 / 100
Momentum Score
Technically Neutral
43.5 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
35
1Yr Price target upside is 76%
18 analysts

14

S

10

W

6

O

1

T

SWOT Analysis

Apellis Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..